Xconomy: Hervé Affagard News, Articles and Opinions

“herve-affagard” Archives

Entry	Author	Date	Location
Why 2020 Is Pivotal for Microbiome Drug R&D (Or Maybe 2021, Given COVID-19)	Frank Vinluan	04/22/20	National
Page 1 of 1

Underwriters and Partners

Xconomy Insight

Sponsored · Whitepaper
CMC in Drug Development and Life Cycle Management
CMC in Drug Development and Life Cycle Management
PRA Health Sciences

Sponsored · Whitepaper
The Importance of Early Key Opinion Leader Outreach in the Biologics & Biosimilars Marketplace
Acknowledging various stakeholder networks and regulatory environment variances is essential to uncover the right decision-makers in support of biologics or biosimilars
IBM Watson

Sponsored · Whitepaper
How Healthy Are Your Market Access Programs?
A Guide to Performing Check-ups on Pharmaceutical Distribution & Patient Access Programs
Archbow Consulting

Xconomy on Demand

We offer a number of ways to subscribe for free!